期刊文献+

内皮素1及其受体基因表达与心房颤动的相关性研究

The relationship of expression of endothelin system with atrial fibrillation
原文传递
导出
摘要 目的检测内皮素-1(ET-1)及其受体(ET—A和ET—B)mRNA在心房颤动(房颤)患者心房组织中的表达,探讨房颤患者心房电重构的分子机制。方法25例行心脏手术的患者分为3组,其中窦性心律组10例,持续性房颤组10例,阵发性房颤5例,于手术中获取右心耳组织,采用实时荧光定量聚合酶链式反应(FQ—PCR)方法检测ET-1前体(Pro—ET-1)、ET—A、ET—B的mRNA表达。结果(1)与窦性心律组相比,Pro-ET-1的mRNA水平在阵发性房颤组、持续性房颤组心房组织中均明显增加(P〈0.05),持续性房颤组较阵发性房颤组亦明显增加(P〈0.05)。(2)与窦性心律组相比,ET—A和ET—B的mRNA水平在阵发性房颤组、持续性房颤组心房组织中明显降低(P〈0.05),持续性房颤组较阵发性房颤组亦明显降低(P〈0.05)。结论房颤患者心房组织中内皮系统基因表达的变化可能是影响心房重构的分子机制之一,与房颤的发生和维持有关。 Objective To determin the mRNA level of the endothelin system in patients with atrial fi- brillation(AF) ,and to explore the molecule mechanisms of atrial electrical remodeling. Methods The right at- rial tissue samples were taken from 25 patients with cardiac surgery. Ten patients were in sinus rhythm, 10 pa- tients had persistent AF and 5 patients had paroxysmal AF. The mRNA level of pro-endothelin- 1, endothelin re- ceptor A and B were studied by real-time fluorescence quantitative PCR (FQ-PCR) method. Results ( 1 ) The mRNA level of pro-endothelin-I significantly increased in both paroxysmal AF and persistent AF groups com- pared with the sinus rhythm group( P 〈 O. 05 ). The significant difference in pro-endothelin-1 was also observed between the persistent AF and paroxysmal AF groups( P 〈 0.05 ). (2)The mRNA level of endothelin receptor A and B significantly decreased in both paroxysmal AF and persistent AF groups compared with the sinus rhythm group(P 〈0. 05). The significant difference in endothelin receptor A and B was also observed between the per- sistent AF and paroxysmal AF groups (P 〈 0. 05). Conclusion The change of expression of endothelin system in patients with atrial fibrillation is possibly one of the molecule mechanism of atrial remodeling and related with the genesis and maintenance of atrial fibrillation.
出处 《中华心律失常学杂志》 2009年第1期53-57,共5页 Chinese Journal of Cardiac Arrhythmias
关键词 心房颤动 心房重构 内皮素 内皮素受体 Atrial fibrillation Atrial remodeling Endothelin Endothelin receptor
  • 相关文献

参考文献13

  • 1Nattel S, Li D, Yue L. Basic mechanisms of atrial fibrillation-very new insights into very old ideas. Annu Revphysiol, 2000,62 : 51 - 77.
  • 2Guglielmini C, Chetboul V, Pietra M, et al. Influence of left atrial enlargement and body weight on the development of atrial fibrillation : retrospective study on 205 dogs. Vet J,2000 ,160 :235-241.
  • 3Tsang TS, Barnes ME, Bailey KR, et al. Left atrial volume : important risk marker of incident atrial fibrillation in 1655 older men and women. Mayo Clin Proc ,2001,76:467-475.
  • 4Ausma J, Dispersyn GD, Duimel H, et al. Changes in uhrastruetural calcium distribution in goat atria during atrial fibrillation. J Mol Cell Cardiol 2000,32:355-364.
  • 5Sun H, Chartier D, Leblanc N, et al. Intracellular calcium changes and tachycardia-induced contractile dysfunction in canine atrial myocytes. Cardiovasc Res,2001,49:751-761.
  • 6Alvarez BV, Perez NG, Ennis IL, et al. Mechanisms underlying the increase in force and Ca^2+ transient that follow stretch of cardiac muscle:a possible explanation of the Anrep effect. Circ Res, 1999, 716 -722.
  • 7He JQ, Pi Y, Walker J, et al. Endothelin-1 and photoreleased diacylycerol increase L-type Ca^2+ current by activation of protein kinase C in rat ventricular myocytes. J Physiol,2000,524:807-820.
  • 8Redpath C J, Rankin AC, Kane KA, et al. Anti-adrenergic effects of endothelin on human atrial action potentials are potentially anti-arrhythmic. J Mol Cell Cardiol,2006,40:717-724.
  • 9Brundel BJ,Van Gelder IC, Tuinenburg AE, et al. Endothelin system in human persistent and paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol,2001,12 :737-742.
  • 10Kiss O, Zima E, Soos P, et al. Intracornary endothelin-1 infusion combined with systemic isoproterenol treatment:antagonistic arrhythmogenic effects. Life Sci ,2004,18 :75 :537-548.

二级参考文献9

  • 1Fareh S, Benardean A, Thibault B, et al. The L-type Ca2+ channel blocker mibefradil prevents the development of a substrate for atrial fibrillation by tachycardia -induced atrial remodeling in dogs. Circulation, 1999,100:2191-2197.
  • 2Nattel S. New ideas about atrial fibrillation 50 years on.Nature, 2000,415:219- 226.
  • 3Schoffen U, Ausma J, Stellbrink C, et al. Cellular mechanism of depressed atrial atrial contractility in patients with chronic atrial fibrillation. Circulation, 2001, 103:691-698.
  • 4Tuinenburg A E,Van Veldhuisen D J,Boomsma,et al.Comparison of plasma neurohormones in congestive heart failure patients with atrial fibrillation versus patients with sinus rhythm. Am J Cardiol, 1998,81:1207-1210.
  • 5Brundel B J,Vangelder I C,Tuinenburg A E,et al. Endothelin system in human persistent and paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol, 2001, 12:732-742.
  • 6Daound E G,Knight B P,Weiss R,et al. Effect of verapamil and procainamide on atrial fibrillation- induced electrial remodeling in humans. Circulation, 1997, 96:1542-1550.
  • 7Lai L P,Su M J,Lin J L,et al. Down-regulation of Ltype calcium channel and sarcoplasmic reticular Ca (2+)-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor,calsequestrin and phospholamban: an insight int
  • 8DieffenbachCW 见:黄培堂 译.引物设计[A].见:黄培堂,译.PCR技术实验指南[C].北京:科学出版社,1998.88-94.
  • 9抗心律失常药物治疗专题组.抗心律失常药物治疗建议[J].中华心血管病杂志,2001,29(6):323-336. 被引量:788

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部